Table 5.
The experimental values for 99mTc-cMORF accumulation in normal organs as a function of the pretargeting interval based on experimental results obtained earlier (10) compared with predicted values (Mean ± 2SDs.
2d | 3d | 4d | ||||
---|---|---|---|---|---|---|
Normal organ | Experimental | Predicted | Experimental | Predicted | Experimental | Predicted |
Liver | 0.60 ± 0.10 | 0.67 ± 0.20 | 0.54 ± 0.06 | 0.48 ± 0.14 | 0.37 ± 0.04 | 0.38 ±0.12 |
Heart | 0.30 ± 0.14 | 0.37 ± 0.18 | 0.22 ± 0.06 | 0.27 ± 0.14 | 0.14 ± 0.04 | 0.22 ± 0.12 |
Kidney | 4.96 ± 2.78 | 5.44 ± 3.02 | 5.28 ± 0.70 | 5.44 ± 3.02 | 4.87 ± 1.72 | 5.44 ± 3.02 |
Lung | 0.74 ± 0.32 | 0.64 ± 0.32 | 0.41 ± 0.14 | 040 ± 0.20 | 0.37 ± 0.18 | 0.26 ± 0.14 |
Spleen | 0.33 ± 0.12 | 0.32 ± 0.16 | 0.29 ± 0.10 | 0.20 ± 0.10 | 0.22 ± 0.08 | 0.13 ± 0.06 |
Muscle | 0.19 ± 0.04 | 0.17 ± 0.08 | 0.13 ± 0.04 | 0.11 ± 0.06 | 0.09 ± 0.02 | 0.07 ± 0.04 |
Blood | 1.27 ± 0.17 | 1.38 ± 0.69 | 0.93 ± 0.08 | 0.77 ± 0.38 | 0.58 ± 0.13 | 0.44 ± 0.22 |